All Stories

  1. Luxeptinib interferes with LYN-mediated activation of SYK and modulates BCR signaling in lymphoma
  2. The copper transporter 1 (CTR1) is required to maintain the stability of copper transporter 2 (CTR2)
  3. Copper transporter 2 regulates intracellular copper and sensitivity to cisplatin